Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer

Translational Oncology

Volumn 6, Issue 6, 2013, Pages 697-702

  Yu, Yue ^a   Chen, Zhaoli ^a   Dong, Jingsi ^a   Wei, Peng ^b   Hu, Rongjun ^b   Zhou, Chengcheng ^a   Sun, Nan ^a   Luo, Mei ^a   Yang, Wenjing ^a   Yao, Ran ^a   Gao, Yibo ^a   Li, Jiagen ^a   Yang, Guohua ^b   He, Wei ^b   He, Jie ^a  

^a CANCER HOSPITAL   (China)

^b Department of Research and Development   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891724501     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.13535     Document Type: Article

References (20)

1. Jemal A, Siegel R, Xu J, and Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin 60, 277-300.
2. Oak CH, Wilson D, Lee HJ, Lim HJ, and Park EK (2012). Potential molecular approaches for the early diagnosis of lung cancer (review). Mol Med Rep 6, 931-936.
3. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, et al. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365, 395-409.
4. Zompatori M, Mascalchi M, Ciccarese F, Sverzellati N, and Pastorino U (2013). Screening for lung cancer using low-dose spiral CT: 10 years later, state of the art. Radiol Med 118, 51-61.
5. Gorges TM, Tinhofer I, Drosch M, Röse L, Zollner TM, Krahn T, and von Ahsen O (2012). Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 12, 178.
6. Young R, Pailler E, Billiot F, Drusch F, Barthelemy A, Oulhen M, Besse B, Soria JC, Farace F, and Vielh P (2012). Circulating tumor cells in lung cancer. Acta Cytol 56, 655-660.
7. Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, Greystoke A, Ward TH, Ferraldeschi R, Hughes A, Clack G, et al. (2011). Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 29, 1556-1563.
8. Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, and Leamon CP (2005). Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338, 284-293.
9. He W, Kularatne SA, Kalli KR, Prendergast FG, Amato RJ, Klee GG, Hartmann LC, and Low PS (2008). Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. Int J Cancer 123, 1968-1973.
10. He W, Wang H, Hartmann LC, Cheng JX, and Low PS (2007). In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci USA 104, 11760-11765.
11. Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, Xiao L, Bedrosian I, Kuerer HM, and Krishnamurthy S (2012). Circulating tumour cells in nonmetastatic breast cancer: a prospective study. Lancet Oncol 13, 688-695.
12. Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, and Farace F (2011). Detection of circulating tumour cells with a hybrid (epithelial/ mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer 105, 1338-1341.
13. Hofman V, Ilie MI, Long E, Selva E, Bonnetaud C, Molina T, Vénissac N, Mouroux J, Vielh P, and Hofman P (2011). Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method. Int J Cancer 129, 1651-1660.
14. Hofman VJ, Ilie MI, Bonnetaud C, Selva E, Long E, Molina T, Vignaud JM, Flejou JF, Lantuejoul S, Piaton E, et al. (2011). Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. Am J Clin Pathol 135, 146-156.
15. Thomas A, Maltzman J, and Hassan R (2013). Farletuzumab in lung cancer. Lung Cancer 80, 15-18.
16. Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, Kadara H, Hofstetter W, Kalhor N, Lee JJ, Franklin W, et al. (2012). High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation. J Thorac Oncol 7, 833-840.
17. Klein CA (2009). Parallel progression of primary tumours and metastases. Nat Rev Cancer 9, 302-312.
18. Joosse SA and Pantel K (2013). Biologic challenges in the detection of circulating tumor cells. Cancer Res 73, 8-11.
19. Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, et al. (2012). EMT and dissemination precede pancreatic tumor formation. Cell 148, 349-361.
20. Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, Sanders RA Jr, and Terstappen LW (2005). Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 27, 49-57.